Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00016755
DRKS00016755
Completed
未知

Multicenter randomized controlled trial exploring postoperative complications and mobilization following major abdominal surgery with vs. without fitness tracker-based feedback (EXPELLIARMUS) - a CHIR-Net Student-Initiated German Medical Audit trial (CHIR-Net SIGMA trial) - EXPELLIARMUS

niversitätsklinikum Ulm0 sites348 target enrollmentMarch 6, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinikum Ulm
Enrollment
348
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2019
End Date
November 22, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Ulm

Eligibility Criteria

Inclusion Criteria

  • •Preoperative inclusion criteria:
  • •1\. Patients scheduled for elective major abdominal surgery defined as procedures expected to last more than 2 hours, or with an anticipated blood loss greater than 500 ml
  • •2\. Ability to understand the character and individual consequences of the clinical trial
  • •3\. Open or laparoscopic or robotic surgery or any variant (laparoscopic\-assisted, hybrid procedures etc.)
  • •4\. Written informed consent
  • •5\. Age \=18 years
  • •Intra\-/postoperative inclusion criteria:
  • •1\. Expected postoperative stay on the intensive care or intermediate care ward is less than 4 days.
  • •2\. No planned reoperation within 30 days
  • •3\. Confirmed major abdominal surgery (\=defined as procedures expected to last more than 2 hours, or with an anticipated blood loss greater than 500 ml.

Exclusion Criteria

  • •1\. American Society of Anesthesiologists (ASA) grade \>3
  • •2\. Preoperative immobility or inability to walk unaided
  • •3\. Participation in another interventional trial with interference of intervention and outcome of this study
  • •4\. Expected postoperative stay on the intensive care or intermediate care ward \>\= 4 days
  • •5\. Planned reoperation within 30 days after index operation
  • •6\. Planned abdominal\-thoracic operations (two\-field surgeries)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Randomized controlled multicenter trial assessing Roux-en-Y anastomosis of the pancreatic stump to prevent pancreatic fistula following distal pancreatectomydisease of pancreatic body and tail
JPRN-UMIN000005722Wakayama Medical University, School of Medicine136
Not yet recruiting
Not Applicable
Download Useful Kind of App for Your Health Studymetabolic syndrome
JPRN-UMIN000042986Japan Agency for Medical Research and Development1,000
Recruiting
Not Applicable
Multi-center randomized controlled trial to evaluate oral vitamin B12 treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patientsgastric cancer
JPRN-UMIN000030727yokohama city university160
Not yet recruiting
Not Applicable
Multicentered randomized controlled trial to test the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered.Urinary incontinence. Unintentional urinary loss.100465901004682810029903
NL-OMON30485Academisch Medisch Centrum290
Recruiting
Phase 1
Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome
CTIS2022-501780-41-00Z Leuven200